作者
Shun Kaneko,Yasuhiro Asahina,Miyako Murakawa,Shunsuke Ueyama,Chiaki Maeyashiki,Hideki Watanabe,Akiko Kusano‐Kitazume,Ayako Sato,Kozue Uchidate,Takehito Asakawa,Sho Watanabe,Yasuhiro Iizuka,Isamu Shibata,Shinya Oooka,Yuko Karakama,Takashi Fujii,Taro Watabe,Keiichi Akahoshi,Minoru Tanabe,Kento Inada,Tomohiro Mochida,Keiya Watakabe,Taro Shimizu,Jun Tsuchiya,Masato Miyoshi,Fukiko Kitahata‐Kawai,Sayuri Nitta,Mina Nakagawa,Sei Kakinuma,Ryuichi Okamoto
摘要
C-reactive protein (CRP) is both an inflammatory and prognostic marker in various cancers. This study aimed to elucidate the characteristics of CRP and the prognostic factors in patients who were administered with atezolizumab plus bevacizumab (ATZ + BEV) for unresectable hepatocellular carcinoma (HCC).
SYLH
浦肯野
杳鸢
凩飒
MchemG
pcr163
djsj
jyy
Eve丶Paopaoxuan
我是站长才怪
kk
hans2400
樱桃猴子
Tanyang
CodeCraft
pluto
赵毓萱
传奇3
敖启航
请叫我风吹麦浪
皖公网安备34019202002308
